Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | SGN-PDL1V |
Trade Name | |
Synonyms | SGNPDL1V|SGN PDL1V |
Drug Descriptions |
SGN-PDL1V is an antibody-drug conjugate (ADC) comprised of a monoclonal antibody targeting CD274 (PD-L1) linked to monomethyl auristatin E (MMAE), which potentially induces cytotoxicity, immune activation, and inhibition of tumor growth (J of Clin Oncol 40, no. 16_suppl (June 01, 2022) TPS3154). |
DrugClasses | PD-L1/PD-1 antibody 121 |
CAS Registry Number | NA |
NCIT ID | C186368 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
SGN-PDL1V | SGN-PDL1V | 0 | 1 |